7:00am
Registration/Visit Exhibits
7:30-8:30am
Breakfast - Product Theatre I - Non-CME
8:40-8:45
Welcome and Introductory Remarks Christina Economides, MD, MM, FSCAI
8:45-9:05
Cardiovascular Disease in Women: 2024 Update Christina Economides, MD, MM, FSCAI
9:05-9:25
Sex Differences in Therapies and Outcomes of Heart Failure in Women Michelle Kittleson, MD, PhD, FACC
9:25-9:45
Glucagon-Like Peptide 1 (GLP-1) Agonists for Prevention and Treatment of Cardiovascular Disease in Women Karol Watson, MD, PhD, FACC
9:45-10:05
Evaluation and Therapies for Coronary Microvascular Disease Janet Wei, MD, FACC
10:05-10:20
Question & Answer
10:20-10:35
Break / Visit Exhibits
10:35-10:55
Sex Differences in Deep Vein Thrombosis, Pulmonary Embolism and May-Thurner Syndrome Guy Mayeda, MD, FACC
10:55-11:15
Treatment of Resistant Hypertension and Role of Novel Device Therapies Katrine Zhiroff, MD, FACC, FSCAI
11:15-11:35
Sex Differences in the Percutaneous Treatments of Valvular Heart Disease Steven Burstein, MD, FACC
11:35-11:55
Sex Differences in Drug and Device Therapy in Cardiac Arrhythmias Ulrika Birgersdotter-Green, MD
11:55-12:10
12:20-1:20
Lunch - Product Theatre I (Non-CME)
1:30-1:50
Cardiovascular Disease Risk During Reproductive Years: Assessment and Management Priya Pillutla, MD, FACC
1:50-2:10
Peripartum Cardiomyopathy: Current State of Knowledge, Treatment and Implications Uri Elkayam, MD, FACC
2:10-2:30
Novel Cholesterol Lowering Agents and Guideline Recommendations Margo B. Minissian, PhD, ACNP, FAHA, AACC
2:30-2:45
2:45-3:00
3:00-3:20
Increasing Gender Representation in the Cardiovascular Work-Force Christina Economides, MD, MM, FSCAI Katrine Zhiroff, MD, FACC, FSCAI Steven Burstein, MD, FACC
3:20-3:40
Clinical Vignettes: New Therapeutic Agents Hypertrophic Obstructive Cardiomyopathy (HOCM) Pulmonary Arterial Hypertension (PAH) Update on Amyloidosis in Female Patients
Symposia Faculty Moderators: Christina Economides, MD, MM, FSCAI Katrine Zhiroff, MD, FACC, FSCAI
3:40-4:40
Trial Updates Using Case-Based Presentations: Sex Differences in Heart Failure Following Acute Coronary Syndromes Long-term Clinical Outcomes in Women Treated with Barostim for Heart Failure with Reduced Ejection Fracture (HFrEF) Update on EMPOWER Trial: IVL for Calcified CAD in Women Update on Therapy for Recurrent Pericarditis Outcomes of Cardiogenic Shock and PCI in Women Treated with Mechanical Circulatory Support
Moderators: Christin Economides, MD, MM, FSCAI Katrine Zhiroff, MD, FACC, FSCAI
4:40-4:55
4:55
Closing Remarks / Adjourn